Order worth $250 or above
and enjoy FREE SHIPPING
Free shipping
Bolstran 150 Mg Injection
Bolstran 150 Mg Injection
Trusted Source-
Effective treatment for moderate to severe Asthma
-
WHO-approved active ingredient (Omalizumab)
-
Shows improvement within 16 weeks
-
Reduces Asthma attacks by up to 75%
-
Dispatch within 24 hours
Medically Reviewed by Dr. Akansha Kaushal
Written by Julian Carter
What is Bolstran 150?
Bolstran 150 is a prescription medication containing Omalizumab, a monoclonal antibody that treats moderate to severe Asthma. This injectable medication belongs to the class of anti-IgE antibodies and works by reducing allergic inflammation in the airways.
Manufactured by Cipla Ltd, Bolstran 150 helps people who don't respond adequately to standard Asthma treatments.
Uses of Bolstran 150
Bolstran is primarily prescribed for:
- Moderate to severe allergic Asthma in people whose symptoms are inadequately controlled with inhaled corticosteroids.
- Chronic idiopathic urticaria (persistent hives) that hasn't responded to antihistamine treatment.
- Severe allergic rhinitis when other treatments haven't worked effectively.
The medication is particularly beneficial for people who experience frequent Asthma attacks despite using other Asthma medications regularly.
Working and benefits of Omalizumab
Omalizumab, the active ingredient in Bolstran injection, works by targeting and blocking immunoglobulin E (IgE), an antibody that triggers allergic reactions in the body. When IgE is blocked, it prevents the release of chemicals that cause airway inflammation and Asthma symptoms.
Key benefits of Omalizumab include:
- Reduced frequency of Asthma attacks: Patients experience fewer severe Asthma episodes and emergency visits.
- Improved lung function: Enhanced breathing capacity and better airflow through the airways.
- Decreased medication dependence: Many people can reduce their reliance on oral corticosteroids.
- Long-term control: Provides sustained improvement in Asthma symptoms with regular use.
- Enhanced quality of life: Individuals report better sleep, increased activity levels, and fewer Asthma-related limitations.
The medication begins showing effectiveness within 16 weeks of starting treatment, with many patients experiencing significant improvement in their Asthma control.
Dosage and how to take Bolstran 150
Bolstran is administered as a subcutaneous (under the skin) injection. Always follow your healthcare provider's specific dosing instructions for optimal results. Here's the recommended usage:
- Typically given every 2 or 4 weeks as determined by your healthcare provider.
- It must be administered by a medical professional in a clinical setting.
- Dosage is based on body weight and blood IgE levels.
Side effects
While Bolstran injection is generally well-tolerated, some users may experience:
- Injection site reactions
- Headache
- Joint pain
- Fatigue
- Upper respiratory tract infection
- Nausea
Most side effects are mild and temporary. However, contact your healthcare provider if you experience severe or persistent symptoms.
Interactions
Certain medicines and diseases can interact with Bolstran.
Drug interactions
Bolstran 150 may interact with:
- Live vaccines
- Immunosuppressant medications
- Blood thinners
- Other biological medications
Disease interactions
Special consideration is needed for patients with:
- Pre-existing parasitic infections: Bolstran may weaken the immune system, making it harder for the body to fight off parasitic infections. This could worsen the infection or make it more difficult to treat.
- Systemic lupus erythematosus: Bolstran may worsen lupus symptoms, which is an autoimmune disease. This is because Bolstran can cause inflammation, a key symptom of lupus.
Food interactions
No significant food interactions have been reported with Bolstran. However, avoid known food allergens that might trigger Asthma symptoms.
Precautions
- Inform the healthcare professional about any allergies or previous severe allergic reactions.
- Requires monitoring for at least 2 hours after the first injection.
- Not suitable for treating acute Asthma attacks or status Asthmaticus.
- Pregnant and nursing mothers should inform their doctors.
- Monitor for signs of parasitic infections during treatment.
- Report unusual symptoms to the doctor immediately.
- Keep all follow-up appointments for proper monitoring.
Why buy from us
At GoodRxMedicine, we provide premium quality Bolstran with these benefits:
- Competitive pricing and regular discounts
- Authentic medication with quality assurance
- Professional healthcare support
- Quick and reliable delivery
- Expert guidance on medication usage
Write a review
How is Bolstran 150 mg Injection administered?
Bolstran 150 mg Injection is administered as a subcutaneous (under the skin) injection by a healthcare professional in a clinical setting. This injection is typically given in the upper arm, thigh, or abdomen, and patients are monitored for at least 2 hours after their first dose.
Can Bolstran 150 mg Injection be taken with other medications?
Yes, Bolstran 150 mg Injection can generally be taken with other Asthma medications. However, always inform your healthcare provider about all medicines you take to avoid potential interactions and ensure safe treatment.
Can Bolstran 150 mg Injection be used for long-term treatment?
Yes, Bolstran 150 mg Injection is safe for long-term use if prescribed by a healthcare provider. Regular monitoring helps ensure continued effectiveness, reduced side effects, and safety throughout the treatment period.
Can I drink alcohol while using Bolstran 150 mg Injection?
While there are no direct interactions between alcohol and Bolstran 150 mg Injection, it's recommended to avoid alcohol as it can trigger Asthma symptoms and potentially reduce the effectiveness of your overall Asthma treatment.
Can Bolstran 150 mg Injection be used in children or elderly patients?
Yes, Bolstran 150 mg Injection can be used in children aged 6 years and older and elderly patients with appropriate dose adjustments. However, treatment should be closely monitored by a healthcare provider in these age groups.
